Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway

BACKGROUND: Prevention of metabolic complications of long‐term adjuvant endocrine therapy in breast cancers remained a challenge. We aimed to investigate the molecular mechanism in the development of tamoxifen (TAM)‐induced fatty liver in both estrogen receptor (ER)‐positive and ER‐negative breast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Liuyun, Tang, Hanmin, Luo, Zhenzhen, Sun, Xiao, Tan, Xinyue, Xie, Lina, Lei, Yutiantian, Cai, Mengjiao, He, Chenchen, Ma, Jinlu, Han, Suxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240857/
https://www.ncbi.nlm.nih.gov/pubmed/32508033
http://dx.doi.org/10.1002/ctm2.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240857/
https://www.ncbi.nlm.nih.gov/pubmed/32508033
http://dx.doi.org/10.1002/ctm2.5

Ejemplares similares